Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Nuvation Bio Inc
(NY:
NUVB
)
2.800
+0.100 (+3.70%)
Official Closing Price
Updated: 4:10 PM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
3,432,539
Open
2.710
Bid (Size)
2.750 (10)
Ask (Size)
2.920 (4)
Prev. Close
2.700
Today's Range
2.655 - 2.810
52wk Range
1.220 - 4.160
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Nuvation Bio to Present at the Jefferies London Healthcare Conference
November 12, 2024
From
Nuvation Bio Inc.
Via
Business Wire
Top 4 Health Care Stocks That May Plunge This Quarter
November 11, 2024
Via
Benzinga
Performance
YTD
+78.34%
+78.34%
1 Month
+16.18%
+16.18%
3 Month
N/A
N/A
6 Month
-9.09%
-9.09%
1 Year
+122.22%
+122.22%
More News
Read More
Nuvation Bio Reports Third Quarter 2024 Financial Results and Provides Business Update
November 06, 2024
From
Nuvation Bio Inc.
Via
Business Wire
Fastenal Posts Upbeat Earnings, Joins Wells Fargo, JPMorgan And Other Big Stocks Moving Higher On Friday
October 11, 2024
Via
Benzinga
Nuvation Bio Appoints Industry Veteran Philippe Sauvage as Chief Financial Officer
October 07, 2024
From
Nuvation Bio Inc.
Via
Business Wire
Positive Pooled Data from Nuvation Bio’s TRUST-I and TRUST-II Studies Highlight Taletrectinib’s Best-in-Class Potential for Patients with Advanced ROS1-positive NSCLC, Supporting Planned New Drug Application Submission in the Fourth Quarter of 2024
September 14, 2024
From
Nuvation Bio Inc.
Via
Business Wire
Why Oracle Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
September 10, 2024
Via
Benzinga
Nuvation Bio to Present at the Cantor Global Healthcare Conference
September 09, 2024
From
Nuvation Bio
Via
Business Wire
Small-Cap Cancer-Focused Nuvation Bio Pulls Plug On Early-Stage Program After Considering Phase 1 Solid Tumor Data
August 05, 2024
Via
Benzinga
Nuvation Bio Reports Second Quarter 2024 Financial Results and Provides Business Update
August 05, 2024
From
Nuvation Bio Inc.
Via
Business Wire
Nuvation Bio Announces Updates and Upcoming Presentations for its ROS1 Inhibitor, Taletrectinib
July 23, 2024
From
Nuvation Bio Inc.
Via
Business Wire
NeuroBo Pharmaceuticals And 2 Other Penny Stocks Insiders Are Buying
June 26, 2024
Via
Benzinga
Nuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1 Inhibitor, Taletrectinib, are Published in the Journal of Clinical Oncology and Reported at 2024 ASCO Annual Meeting
June 01, 2024
From
Nuvation Bio Inc.
Via
Business Wire
Nuvation Bio to Present at the Jefferies Global Healthcare Conference
May 29, 2024
From
Nuvation Bio Inc.
Via
Business Wire
NUVB Stock Earnings: Nuvation Bio Beats EPS for Q1 2024
May 14, 2024
Via
InvestorPlace
Nuvation Bio Reports First Quarter 2024 Financial Results and Provides Business Update
May 14, 2024
From
Nuvation Bio Inc.
Via
Business Wire
Nuvation Bio to Present Updated Data on Taletrectinib, a ROS1 inhibitor, at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
April 24, 2024
From
Nuvation Bio Inc.
Via
Business Wire
Fifth Third Bancorp Reports Upbeat Earnings, Joins Metropolitan Bank Holding, Paramount Global And Other Big Stocks Moving Higher On Friday
April 19, 2024
Via
Benzinga
Nuvation Bio Completes Acquisition of AnHeart Therapeutics
April 10, 2024
From
Nuvation Bio Inc.
Via
Business Wire
ProfoundBio Discovers The Joys Of Having A Wealthy Owner
April 08, 2024
Via
Benzinga
Intel, XPeng And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
April 03, 2024
Via
Benzinga
Week In Review: AriBio Sells China Rights To Alzheimer’s Candidate In $770 Million Deal
March 30, 2024
Via
Talk Markets
Nuvation Bio Announces Appointment of Colleen Sjogren as Chief Commercial Officer
March 28, 2024
From
Nuvation Bio Inc.
Via
Business Wire
Why LuxUrban Hotels Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 27, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
March 27, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.